Cellab CDMO

Cellab CDMO is a specialized advanced-therapy CDMO that combines cell banking and GMP manufacturing under a unified quality framework. Its end-to-end model supports a therapy from early development through clinical application.

Services

• Process development, starting material sourcing, GMP manufacturing, cryopreservation, quality and regulatory support
• Tailor-made services from bioprocess scaling to GMP batch release and QP release across Europe
• Temperature-controlled international transport of biological samples and ATMPs, including time-critical shipments
• Accredited AABB cell bank with 24/7 monitoring for quality, security and traceability

Platforms

The company supports autologous and allogeneic cell therapies and gene-modified products, including MSC, CAR-T, HSC/HPC, PBMC/T cell and iPSC programs.

Facilities

• Purpose-built facility of over 1,000 m²
• Four Grade B cleanrooms and one Grade C cleanroom
• Two QC laboratories
• 50 m² cryogenic storage
• Modular, independent cleanroom design enabling parallel manufacturing

Clients

Cellab works with biotech and pharmaceutical companies developing cell and gene therapies, hospitals and clinical centers, and research institutions with translational programs.